SAMANTHA RICHARD: Open Payments
NPI 1497325997 · RUSSELLVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 17 payments from 8 companies in 2025. Trend: 2023 $415 · 2024 $326 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $75 |
| ABBVIE INC. | 3 | $65 |
| Antares Pharma, Inc. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Novo Nordisk Inc | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Amgen Inc. | 1 | $16 |
Products named: MOUNJARO, XYOSTED, CAPLYTA, REXULTI, UBRELVY, QULIPTA, ZEPBOUND, Ozempic.
Industry payments across AR — which companies pay providers there.
